Vimarsana
Biggest News Aggregation in the World

Page 2 - Theranostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Theranostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Theranostics Inc Today - Breaking & Trending Today

Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement - Vimarsana News

Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Contract/Incoming Orders Eckert & Ziegler and Alpha-9 Sign Actinium-225 Reservation Agreement... | October 13, 2022

Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials - Vimarsana News

Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract23.03.2022 / 10:16 The issuer is solely responsible for the content of this announcement.Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Th...

DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials Seite 1 - Vimarsana News

DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials Seite 1

23.03.2022 - DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials 23.03.2022 / 10:16 The issuer is solely responsible ... Seite 1

Worldwide Polymerase Chain Reaction (PCR) for Point-of-Care Diagnostics Industry to 2025 - Vimarsana News

Worldwide Polymerase Chain Reaction (PCR) for Point-of-Care Diagnostics Industry to 2025

Share this article Share this article ResearchAndMarkets.com's offering. The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users. Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers. The report also includes a discussion on the major players in each regional market. Further, it explains major drivers and regional dynamics of the global market. The report concludes with a look at the ve...